The Philippines' national university hospital, whose Cancer Institute is the country's main public referral centre for oncology and the site of its cancer control research.
The Philippine General Hospital opened in 1907 and is the tertiary teaching hospital of the University of the Philippines Manila and the largest government hospital in the country. Its Cancer Institute provides surgical, medical, radiation and paediatric oncology to a predominantly indigent population, hosts the Philippine Cancer Society's Manila registry collaboration, and leads national work on cervical cancer screening, HPV vaccination, breast cancer early detection and paediatric leukaemia outcomes. PGH researchers and the UP National Institutes of Health inform the National Integrated Cancer Control Act implementation, and the hospital's radiotherapy expansion and philanthropic cancer funds aim to reduce treatment abandonment.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Philippine General Hospital, including child institutions. 92 works · 284 citations · 82% open access · 3% clinical trials · 8% reviews.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Global oncology and access in low- and middle-income countries, Cervical cancer, Acute lymphoblastic leukaemia, Head and neck squamous cell carcinoma.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, Acute lymphoblastic leukaemia.
Shares Global oncology and access in low- and middle-income countries, Cervical cancer, Acute lymphoblastic leukaemia, Head and neck squamous cell carcinoma.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, Acute lymphoblastic leukaemia.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, HR-positive / HER2-negative breast cancer.